#3563
Can tumor absorbed dose predict response to Peptide Receptor Radionuclide Therapy (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)?
Introduction:
Tumor dosimetry protocols following Peptide Receptor Radionuclide Therapy (PRRT) have not yet been standardised and tumor absorbed dose does not hold clear value in predicting response to treatment.
Conference:
Presenting Author:
Mileva M
Authors:
Mileva M,
Marin G,
Levillain H,
van Bogaert C,
Critchi G,
Keywords:
PRRT,
tumor dose,
68Ga-DOTATATE,
SUVmax,
response,
#3313
Carcinoid heart surgery: Review of outcomes from a single large centre
Introduction:
Up to half of patients with carcinoid syndrome develop carcinoid heart disease and valve degeneration can lead to right heart failure. Surgical replacement of affected valves is an effective therapy. Peptide receptor radio-targeted therapy (PRRT) has demonstrated better progression-free survival compared to high dose sandostatin LAR.
Conference:
18th Annual ENETS Concerence (2021)
Presenting Author:
Maclean R
Authors:
Maclean R,
Cope J,
Hota S,
Mulholland N,
Ramage J,
Keywords:
PRRT,
Lutetium,
Lutathera,
carcinoid syndrome,
valve replacement,
#953
Comparison of Diagnostic Methods in the Evaluation of Pancreatic and Duodenal Gastrinomas
Introduction:
Gastrinomas are neuroendocrine tumors, mainly located in the duodenum or the pancreas, that secrete gastrin and cause a clinical syndrome known as ZES.
Conference:
11th Annual ENETSConcerence (2014)
Presenting Author:
Hyrdel P
Authors:
Hyrdel P,
Režnák I,
Dobrota D,
Laca L,
Plank L,
Keywords:
neuroendocrine tumors GIT,
gastrinoma,
effectiveness of tumor markers,
imaging diagnostic methods,
clinical features,
#232
Prognostic Factors and Survival in 481 Patients with Pancreatic and Peripancreatic Endocrine Tumors: Results from the National Cancer Registry of Spain (RGETNE)
Introduction:
Duodenopancreatic neuroendocrine tumors (NETs) are uncommon neoplasms with a wide spectrum of clinical presentation. The infrequent occurrence of these tumors makes large experiences very scarce.
Conference:
8th Annual ENETSConcerence (2011)
Presenting Author:
Authors:
Martin-Perez E,
Capdevila J,
Castellano D,
Jiménez-Lacave A,
Beguiristain-Gómez A,
Keywords:
pancreatic neuroendocrine tumors,
gastrinoma,
glucagonoma,
insulinoma,
registry,
survival,
treatment,
